Literature DB >> 11598120

Multiple activation loop conformations and their regulatory properties in the insulin receptor's kinase domain.

A J Ablooglu1, M Frankel, E Rusinova, J B Ross, R A Kohanski.   

Abstract

Low catalytic efficiency of protein kinases often results from intrasteric inhibition caused by the activation loop blocking the active site. In the insulin receptor's kinase domain, Asp-1161 and Tyr-1162 in the peptide substrate-like sequence of the unphosphorylated activation loop can interact with four invariant residues in the active site: Lys-1085, Asp-1132, Arg-1136, and Gln-1208. Contributions of these six residues to intrasteric inhibition were tested by mutagenesis, and the unphosphorylated kinase domains were characterized. The mutations Q1208S, K1085N, and Y1162F each relieved intrasteric inhibition, increasing catalytic efficiency but without changing the rate-limiting step of the reaction. The mutants R1136Q and D1132N were virtually inactive. Steric accessibility of the active site was ranked by relative changes in iodide quenching of intrinsic fluorescence, and A-loop conformation was ranked by limited tryptic cleavage. Together these ranked the openness of the active site cleft as R1136Q approximately D1132N > or = D1161A > Y1162F approximately K1085N > Q1208S > or = wild-type. These findings demonstrate the importance of specific invariant residues for intrasteric inhibition and show that diverse activation loop conformations can produce similar steady-state kinetic properties. This suggests a broader range of regulatory properties for the activation loop than expected from a simple off-versus-on switch for kinase activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598120     DOI: 10.1074/jbc.M107236200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Catalytic mechanisms and regulation of protein kinases.

Authors:  Zhihong Wang; Philip A Cole
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

Review 2.  Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review.

Authors:  Bhaskar Venkata Kameswara Subrahmanya Lakkakula; Maheswari Thangavelu; Usha Rani Godla
Journal:  J Assist Reprod Genet       Date:  2013-06-22       Impact factor: 3.412

3.  A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome.

Authors:  Reha M Toydemir; Anna E Brassington; Pinar Bayrak-Toydemir; Patrycja A Krakowiak; Lynn B Jorde; Frank G Whitby; Nicola Longo; David H Viskochil; John C Carey; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2006-09-26       Impact factor: 11.025

4.  Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases.

Authors:  Joshua B Sheetz; Sebastian Mathea; Hanna Karvonen; Ketan Malhotra; Deep Chatterjee; Wilhelmiina Niininen; Robert Perttilä; Franziska Preuss; Krishna Suresh; Steven E Stayrook; Yuko Tsutsui; Ravi Radhakrishnan; Daniela Ungureanu; Stefan Knapp; Mark A Lemmon
Journal:  Mol Cell       Date:  2020-07-02       Impact factor: 17.970

5.  PIK3CA somatic mutations in breast cancer: Mechanistic insights from Langevin dynamics simulations.

Authors:  Parminder K Mankoo; Saraswati Sukumar; Rachel Karchin
Journal:  Proteins       Date:  2009-05-01

6.  Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor.

Authors:  Jinhua Wu; Wanqing Li; Barbara P Craddock; Kenneth W Foreman; Mark J Mulvihill; Qun-sheng Ji; W Todd Miller; Stevan R Hubbard
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

7.  SUN11602, a novel aniline compound, mimics the neuroprotective mechanisms of basic fibroblast growth factor.

Authors:  Norihito Murayama; Taisuke Kadoshima; Naohiro Takemoto; Shiho Kodama; Tetsuya Toba; Ryoko Ogino; Takafumi Noshita; Tetsushi Oka; Shinya Ueno; Mariko Kuroda; Yoshiari Shimmyo; Yasuhiro Morita; Teruyoshi Inoue
Journal:  ACS Chem Neurosci       Date:  2012-11-21       Impact factor: 4.418

8.  Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated kinase-1.

Authors:  Ling Zhou; Chunli Yan; Roben G Gieling; Yujiro Kida; Warren Garner; Wei Li; Yuan-Ping Han
Journal:  BMC Immunol       Date:  2009-03-19       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.